Uric acid and skin microvascular function: The Maastricht study

Journal of Hypertension

Volumn 33, Issue 8, 2015, Pages 1651-1657

  Wijnands, José M A ^a,b   Houben, Alfons J H M ^a,c   Muris, Dennis M J ^a,c   Boonen, Annelies ^a,b   Schram, Miranda T ^a,c   Sep, Simone J S ^a,c   Van Der Kallen, Carla J H ^a,c   Henry, Ronald M A ^a,c   Dagnelie, Pieter C ^b,c   Van Der Linden, Sjef ^a,b   Schaper, Nicolaas C ^a,b,c   Arts, Ilja C W ^b,c   Stehouwer, Coen D A ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

capillaries; microcirculation; uric acid

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; ARTERY OCCLUSION; ARTICLE; BODY MASS; CAPILLAROSCOPY; CAPILLARY DENSITY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SKIN CAPILLARY; SKIN FUNCTION; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VENOUS CONGESTION; AGED; ANGIOSCOPY; BLOOD; CAPILLARY; HYPEREMIA; PATHOPHYSIOLOGY; SKIN; VASCULARIZATION;

ADULT; AGED; CAPILLARIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPEREMIA; MALE; MICROCIRCULATION; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; SKIN; URIC ACID;

EID: 84941208689     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000583     Document Type: Article

References (40)

1. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005; 25: 39-42
2. Kanbay M, Sanchez-Lozada LG, Franco M, Madero M, Solak Y, Rodriguez-Iturbe B, et al. Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant 2011; 26: 430-437
3. Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 2005; 25: 425-433
4. Serne EH, Gans RO, ter Maaten JC, Tangelder GJ, Donker AJ, Stehouwer CD. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001; 38: 238-242
5. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011; 63: 102-110
6. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009; 169: 342-350
7. Huang H, Huang B, Li Y, Huang Y, Li J, Yao H, et al. Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail 2014; 16: 15-24
8. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002; 282: F991-F997
9. Sanchez-Lozada LG, Tapia E, Santamaria J, Avila-Casado C, Soto V, Nepomuceno T, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 2005; 67: 237-247
10. Gullu H, Erdogan D, Caliskan M, Tok D, Kulaksizoglu S, Yildirir A, Muderrisoglu H. Elevated serum uric acid levels impair coronary microvascular function in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 2007; 9: 466-468
11. Kuwahata S, Hamasaki S, Ishida S, Kataoka T, Yoshikawa A, Orihara K, et al. Effect of uric acid on coronary microvascular endothelial function in women: association with eGFR and ADMA. J Atheroscler Thromb 2010; 17: 259-269
12. Erdogan D, Tayyar S, Uysal BA, Icli A, Karabacak M, Ozaydin M, Dogan A. Effects of allopurinol on coronary microvascular and left ventricular function in patients with idiopathic dilated cardiomyopathy. Can J Cardiol 2012; 28: 721-727
13. Yuan Y, Ikram MK, Jiang S, Lin H, Ren L, Yan H, et al. Hyperuricemia accompanied with changes in the retinal microcirculation in a Chinese high-risk population for diabetes. Biomed Environ Sci 2011; 24: 146-154
14. Oh CM, Park SK, Ryoo JH. Serum uric acid level is associated with the development of microalbuminuria in Korean men. Eur J Clin Invest 2014; 44: 4-12
15. Chade AR, Brosh D, Higano ST, Lennon RJ, Lerman LO, Lerman A. Mild renal insufficiency is associated with reduced coronary flow in patients with nonobstructive coronary artery disease. Kidney Int 2006; 69: 266-271
16. Holowatz LA, Thompson-Torgerson CS, Kenney WL. The human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol 19852008; 105: 370-372
17. Barchetta I, Riccieri V, Vasile M, Stefanantoni K, Comberiati P, Taverniti L, Cavallo MG. High prevalence of capillary abnormalities in patients with diabetes and association with retinopathy. Diabet Med 2011; 28: 1039-1044
18. Houben AJ, Beljaars JH, Hofstra L, Kroon AA, De Leeuw PW. Microvascular abnormalities in chronic heart failure: a cross-sectional analysis. Microcirculation 2003; 10: 471-478
19. Draaijer P, De Leeuw PW, van Hooff JP, Leunissen KM. Nailfold capillary density in salt-sensitive and salt-resistant borderline hypertension. J Hypertens 1993; 11: 1195-1198
20. Matheus AS, Tibirica E, da Silva PB, De Fatima Bevilacqua da Matta M, Gomes MB. Uric acid levels are associated with microvascular endothelial dysfunction in patients with Type 1 diabetes. Diabet Med 2011; 28: 1188-1193
21. Kawai T, Ohishi M, Takeya Y, Onishi M, Ito N, Yamamoto K, et al. Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients. Hypertens Res 2012; 35: 1087-1092
22. Feig DI. The role of uric acid in the pathogenesis of hypertension in the young. J Clin Hypertens (Greenwich) 2012; 14: 346-352
23. Shankar A, Klein BE, Nieto FJ, Klein R. Association between serum uric acid level and peripheral arterial disease. Atherosclerosis 2008; 196: 749-755
24. Wijnands JMA, Boonen A, Dagnelie PC, Greevenbroek van MMJ, Kallen van der CJ, Ferreira I, et al. The cross-sectional association between uric acid and atherosclerosis, and the role of low-grade inflammation: the CODAM study. Rheumatology (Oxford) 2014; 53: 2053-2062
25. Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E, et al. Serum uric acid and target organ damage in primary hypertension. Hypertension 2005; 45: 991-996
26. Schram MT, Sep SJ, Kallen van der CJ, Dagnelie PC, Koster A, Schaper N, et al. The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities. Eur J Epidemiol 2014; 29: 439-451
27. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992; 45: 1101-1109
28. Gronenschild EH, Muris DM, Schram MT, Karaca U, Stehouwer CD, Houben AJ. Semi-automatic assessment of skin capillary density: proof of principle and validation. Microvasc Res 2013; 90: 192-198
29. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
30. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva, Switzerland: World Health Organization (WHO); 2006
31. Takahashi S, Moriwaki Y, Yamamoto T, Tsutsumi Z, Ka T, Fukuchi M. Effects of combination treatment using antihyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism. Ann Rheum Dis 2003; 62: 572-575
32. Hamada T, Ichida K, Hosoyamada M, Mizuta E, Yanagihara K, Sonoyama K, et al. Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT1) in hypertensive patients. AmJ Hypertens 2008; 21: 1157-1162
33. Chanard J, Toupance O, Lavaud S, Hurault De Ligny B, Bernaud C, Moulin B. Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients. Nephrol Dial Transplant 2003; 18: 2147-2153
34. Ogata N, Fujimori S, Oka Y, Kaneko K. Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients. Nucleosides Nucleotides Nucleic Acids 2010; 29: 321-324
35. Uetake D, Ohno I, Ichida K, Yamaguchi Y, Saikawa H, Endou H, Hosoya T. Effect of fenofibrate on uric acid metabolism and urate transporter 1. Intern Med 2010; 49: 89-94
36. Ochodnicky P, Henning RH, Buikema HJ, De Zeeuw D, Provoost AP, van Dokkum RP. Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat. Am J Physiol Renal Physiol 2010; 298: F625-F633
37. Schubert R, Mulvany MJ. The myogenic response: established facts and attractive hypotheses. Clin Sci (Lond) 1999; 96: 313-326
38. Habazettl H, Pries AR. Microvascular control of myocardial perfusion. Heart Metab 2008; 40: 5-10
39. Yu MA, Sanchez-Lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010; 28: 1234-1242
40. Roustit M, Cracowski JL. Assessment of endothelial and neurovascular function in human skin microcirculation. Trends Pharmacol Sci 2013; 34: 373-384